Evidence for the involvement of 5-HT2A receptors in mild mesenteric ischemia/reperfusion dysfunctions in mice

Pharmacological Research

Volumn 56, Issue 6, 2007, Pages 550-555

  Bertoni, Simona ^a   Ghizzardi, Paola ^a   Cattaruzza, Fiore ^b   Ballabeni, Vigilio ^a   Impicciatore, Mariannina ^a   Tognolini, Massimiliano ^a   Lagrasta, Costanza A M ^a   Barocelli, Elisabetta ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Gastrointestinal transit; Ketanserin; Mesenteric ischemia reperfusion injury; Mice; Platelet aggregation

Indexed keywords

4 IODO 2,5 DIMETHOXYAMPHETAMINE; ADENOSINE DIPHOSPHATE; EVANS BLUE; KETANSERIN; MYELOPEROXIDASE; SEROTONIN 2A RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL INFILTRATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; FEMALE; GASTROINTESTINAL TRANSIT; INTESTINE ISCHEMIA; MESENTERIC ARTERY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; SMALL INTESTINE; THROMBOCYTE AGGREGATION;

AMPHETAMINES; ANIMALS; CAPILLARY PERMEABILITY; FEMALE; GASTROINTESTINAL TRANSIT; INTESTINES; KETANSERIN; LEUKOCYTES; LIPID PEROXIDATION; LUNG; MALONDIALDEHYDE; MESENTERIC ARTERY, SUPERIOR; MICE; PEROXIDASE; PLATELET AGGREGATION; RECEPTOR, SEROTONIN, 5-HT2A; REPERFUSION INJURY; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 36248961683     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2007.10.004     Document Type: Article

References (40)

1. Chang R.W., Chang J.B., and Longo W.E. Update in management of mesenteric ischemia. World J Gastroenterol 12 20 (2006) 3243-3247
2. Ujiki M., and Kibbe M.R. Mesenteric ischemia. Perspect Vasc Surg Endovasc Ther 17 4 (2005) 309-318
3. Carden D.L., and Granger D.N. Pathophysiology of ischaemia-reperfusion injury. J Pathol 190 3 (2000) 255-266
4. Cuzzocrea S., Zingarelli B., Costantino G., Szabo A., Salzman A.L., Caputi A.P., et al. Beneficial effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase in a rat model of splanchnic artery occlusion and reperfusion. Br J Pharmacol 121 6 (1997) 1065-1074
5. Ballabeni V., Barocelli E., Bertoni S., and Impicciatore M. Alterations of intestinal motor responsiveness in a model of mild mesenteric ischemia/reperfusion in rats. Life Sci 71 (2002) 2025-2035
6. Calcina F., Barocelli E., Bertoni S., Furukawa O., Kaunitz J., Impicciatore M., et al. Up-regulation of inhibitory transmitters in myenteric neurons of the rat ileum in an acute model of ischemia/reperfusion. Pharmacologist 44 Suppl (2002) A32
7. Calcina F., Barocelli E., Bertoni S., Furukawa O., Kaunitz J., Impicciatore M., et al. Effect of N-methyl-d-aspartate receptor blockade on neuronal plasticity and gastrointestinal transit delay induced by ischemia/reperfusion in rats. Neuroscience 134 1 (2005) 39-49
8. Barocelli E., Ghizzardi P., Cattaruzza F., Bertoni S., Ballabeni V., and Impicciatore M. Influence of nitric oxide system in mesenteric ischemia-reperfusion induced injury in mice. Fund Clin Pharmacol 18 Suppl 1 (2004) 62
9. Erspamer V., Roseghini M., Endean R., and Anastasi A. Biogenic amines and active polypeptides in the skin of Australian amphibians. Nature 212 5058 (1966) 204-211
10. Tonini M., and Pace F. Drugs acting on serotonin receptors for the treatment of functional GI disorders. Dig Dis 24 1-2 (2006) 59-69
11. Spiller R. Serotonergic modulating drugs for functional gastrointestinal diseases. Br J Clin Pharmacol 54 1 (2002) 11-20
12. Hoyer D., Hannon J.P., and Martin G.R. Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav 71 4 (2002) 533-554
13. Teramoto Y., Urano T., Nagai N., Takada Y., Ikeda K., and Takada A. Plasma levels of 5-HT and 5-HIAA increased after intestinal ischemia/reperfusion in rats. Jpn J Physiol 48 5 (1998) 333-339
14. Choudhury N.A., Malyszko J., Ahmed M.H., Pietraszek M.H., Nakamura S., Nakai K., et al. Plasma serotonin and platelet aggregation during ischemia-reperfusion in dogs: effect of dipyridamole and coenzyme Q10. Haemostasis 26 1 (1996) 38-44
15. Cerqueira N.F., Hussni C.A., and Yoshida W.B. Pathophysiology of mesenteric ischemia/reperfusion: a review. Acta Cir Bras 20 4 (2005) 336-343
16. Hansen M.B., Dresner L.S., and Wait R.B. Profile of neurohumoral agents on mesenteric and intestinal blood flow in health and disease. Physiol Res 47 5 (1998) 307-327
17. Matia I., Balaz P., Jackanin S., Rybarova E., Kron I., Pomfy M., et al. Serotonin levels in the small bowel mucosa as a marker of ischemic injury during small bowel preservation. Ann Transplant 9 3 (2004) 48-51
18. Nakamura N., Hamada N., Murata R., Ishizaki N., Kobayashi A., and Moriyama Y. Liver injury and serotonin production after small intestinal ischemia and reperfusion. Transplant Proc 32 6 (2000) 1301-1309
19. Nakamura N., Hamada N., Murata R., Kobayashi A., Ishizaki N., Taira A., et al. Contribution of serotonin to liver injury following canine small-intestinal ischemia and reperfusion. J Surg Res 99 1 (2001) 17-24
20. 3 receptors in the rat ileum. Am J Physiol Gastrointest Liver Physiol 284 5 (2003) G782-G788
21. Cloëz-Tayarani I., Petit-Bertron A.F., Venters H.D., and Cavaillon J.M. Differential effect of serotonin on cytokine production in lipopolysaccharide-stimulated human peripheral blood mononuclear cells: involvement of 5-hydroxytryptamine2A receptors. Int Immunol 15 2 (2003) 233-240
22. Barocelli E., Ballabeni V., Ghizzardi P., Cattaruzza F., Bertoni S., Lagrasta C.A., et al. The selective inhibition of inducible nitric oxide synthase prevents intestinal ischemia-reperfusion injury in mice. Nitric Oxide 14 3 (2006) 212-218
23. Cattaruzza F., Cenac N., Barocelli E., Impicciatore M., Hyun E., Vergnolle N., et al. Protective effect of proteinase-activated receptor 2 activation on motility impairment and tissue damage induced by intestinal ischemia/reperfusion in rodents. Am J Pathol 169 1 (2006) 177-188
24. Arakawa K., Takeyoshi I., Muraoka M., Matsumoto K., and Morishita Y. Measuring platelet aggregation to estimate small intestinal ischemia-reperfusion injury. J Surg Res 122 2 (2004) 195-200
25. 2 receptor agonist, DOI (2,5-dimethoxy-4-iodoamphetamine), and antagonist, ketanserin, on the performance of rats on a free-operant timing schedule. Behav Pharmacol 14 8 (2003) 599-607
26. Puig M.M., Warner W., and Pol O. Intestinal inflammation and morphine tolerance alter the interaction between morphine and clonidine on gastrointestinal transit in mice. Anesthesiology 93 (2000) 219-230
27. Raffa R.B., Mathiasen J.R., and Jacoby H.I. Colonic bead expulsion time in normal and mu-opioid receptor deficient (CXBK) mice following central (ICV) administration of mu- and delta-opioid agonists. Life Sci 41 19 (1987) 2229-2234
28. Krawisz J.E., Sharon P., and Stenson W.F. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 87 (1984) 1344-1350
29. Ohkawa H., Ohishi N., and Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95 (1979) 351-358
30. Souza D.G., Coutinho S.F., Silveira M.R., Cara D.C., and Teixeira M.M. Effects of a BLT receptor antagonist on local and remote reperfusion injuries after transient ischemia of the superior mesenteric artery in rats. Eur J Pharmacol 403 (2000) 121-128
31. Born G.V. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194 (1962) 927-929
32. Wouters W., Van Dun J., Leysen J.E., and Laduron P.M. Photoaffinity probes for serotonin and histamine receptors. Synthesis and characterization of two azide analogues of ketanserin. J Biol Chem 260 14 (1985) 8423-8429
33. Miner T.J., Tavaf-Motamen H., Stojadinovic A., and Shea-Donohue T. Ischemia-reperfusion protects the rat small intestine against subsequent injury. J Surg Res 82 1 (1999) 1-10
34. Souza D.G., Pinho V., Soares A.C., Shimizu T., Ishii S., and Teixeira M.M. Role of PAF receptors during intestinal ischemia and reperfusion injury. A comparative study between PAF receptor-deficient mice and PAF receptor antagonist treatment. Br J Pharmacol 139 4 (2003) 733-740
35. Aydemir-Koksoy A., Koksoy C., Kuzu M.A., Demirpence E., Cinel I., Kesenci M., et al. Intestinal ischemia-reperfusion leads to platelet dysfunction. Thromb Res 94 6 (1999) 395-400
36. Massberg S., Eisenmenger S., Enders G., Krombach F., and Messmer K. Quantitative analysis of small intestinal microcirculation in the mouse. Res Exp Med (Berl) 198 1 (1998) 23-35
37. Xu Y., Huo Y., Toufektsian M.C., Ramos S.I., Ma Y., Tejani A.D., et al. Activated platelets contribute importantly to myocardial reperfusion injury. Am J Physiol Heart Circ Physiol 290 2 (2006) H692-H699
38. Houkin K., Nakayama N., Nonaka T., and Koyanagi I. The 5-hydroxytryptamine2A receptor antagonist sarpogrelate hydrochloride inhibits acute platelet aggregation in injured endothelium. J Int Med Res 34 1 (2006) 65-72
39. 2 receptor blocker sarpogrelate prevents downregulation of antiapoptotic protein Bcl-2 and protects the heart against ischemia-reperfusion injury. Life Sci 79 18 (2006) 1749-1755
40. 2 receptor blocker, may have a preconditioning-like effect in patients with coronary artery disease. Circ J 68 1 (2004) 68-72